1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Vitamin K Antagonists (VKA) Revenue
1.4 Market Analysis by Type
1.4.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Vitamin K Antagonists
1.4.3 Injection Vitamin K Antagonists
1.5 Market by Application
1.5.1 Global Vitamin K Antagonists (VKA) Market Share by Application: 2021-2026
1.5.2 VTE
1.5.3 ACS/MI
1.5.4 AF
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Vitamin K Antagonists (VKA) Market
1.8.1 Global Vitamin K Antagonists (VKA) Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Vitamin K Antagonists (VKA) Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Vitamin K Antagonists (VKA) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vitamin K Antagonists (VKA) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Vitamin K Antagonists (VKA) Sales Volume Market Share by Region (2015-2020)
3.2 Global Vitamin K Antagonists (VKA) Sales Revenue Market Share by Region (2015-2020)
3.3 North America Vitamin K Antagonists (VKA) Sales Volume
3.3.1 North America Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.3.2 North America Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Vitamin K Antagonists (VKA) Sales Volume
3.4.1 East Asia Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Vitamin K Antagonists (VKA) Sales Volume (2015-2020)
3.5.1 Europe Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Vitamin K Antagonists (VKA) Sales Volume (2015-2020)
3.6.1 South Asia Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Vitamin K Antagonists (VKA) Sales Volume (2015-2020)
3.7.1 Southeast Asia Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Vitamin K Antagonists (VKA) Sales Volume (2015-2020)
3.8.1 Middle East Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Vitamin K Antagonists (VKA) Sales Volume (2015-2020)
3.9.1 Africa Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Vitamin K Antagonists (VKA) Sales Volume (2015-2020)
3.10.1 Oceania Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Vitamin K Antagonists (VKA) Sales Volume (2015-2020)
3.11.1 South America Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.11.2 South America Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Vitamin K Antagonists (VKA) Sales Volume (2015-2020)
3.12.1 Rest of the World Vitamin K Antagonists (VKA) Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Vitamin K Antagonists (VKA) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Vitamin K Antagonists (VKA) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Vitamin K Antagonists (VKA) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Vitamin K Antagonists (VKA) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Vitamin K Antagonists (VKA) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Vitamin K Antagonists (VKA) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Vitamin K Antagonists (VKA) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Vitamin K Antagonists (VKA) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Vitamin K Antagonists (VKA) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Vitamin K Antagonists (VKA) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Vitamin K Antagonists (VKA) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Vitamin K Antagonists (VKA) Sales Volume Market Share by Type (2015-2020)
14.2 Global Vitamin K Antagonists (VKA) Sales Revenue Market Share by Type (2015-2020)
14.3 Global Vitamin K Antagonists (VKA) Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Vitamin K Antagonists (VKA) Consumption Volume by Application (2015-2020)
15.2 Global Vitamin K Antagonists (VKA) Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Vitamin K Antagonists (VKA) Business
16.1 Sanofi
16.1.1 Sanofi Company Profile
16.1.2 Sanofi Vitamin K Antagonists (VKA) Product Specification
16.1.3 Sanofi Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Daiichi Sankyo
16.2.1 Daiichi Sankyo Company Profile
16.2.2 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Specification
16.2.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Johnson & Johnson
16.3.1 Johnson & Johnson Company Profile
16.3.2 Johnson & Johnson Vitamin K Antagonists (VKA) Product Specification
16.3.3 Johnson & Johnson Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Bristol-Myers Squibb
16.4.1 Bristol-Myers Squibb Company Profile
16.4.2 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Specification
16.4.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Lilly
16.5.1 Lilly Company Profile
16.5.2 Lilly Vitamin K Antagonists (VKA) Product Specification
16.5.3 Lilly Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Bayer
16.6.1 Bayer Company Profile
16.6.2 Bayer Vitamin K Antagonists (VKA) Product Specification
16.6.3 Bayer Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 AstraZeneca
16.7.1 AstraZeneca Company Profile
16.7.2 AstraZeneca Vitamin K Antagonists (VKA) Product Specification
16.7.3 AstraZeneca Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Boehringer Ingelheim
16.8.1 Boehringer Ingelheim Company Profile
16.8.2 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Specification
16.8.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Genentech (Roche)
16.9.1 Genentech (Roche) Company Profile
16.9.2 Genentech (Roche) Vitamin K Antagonists (VKA) Product Specification
16.9.3 Genentech (Roche) Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Otsuka
16.10.1 Otsuka Company Profile
16.10.2 Otsuka Vitamin K Antagonists (VKA) Product Specification
16.10.3 Otsuka Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Pfizer
16.11.1 Pfizer Company Profile
16.11.2 Pfizer Vitamin K Antagonists (VKA) Product Specification
16.11.3 Pfizer Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Aspen
16.12.1 Aspen Company Profile
16.12.2 Aspen Vitamin K Antagonists (VKA) Product Specification
16.12.3 Aspen Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 The Medicines Company
16.13.1 The Medicines Company Company Profile
16.13.2 The Medicines Company Vitamin K Antagonists (VKA) Product Specification
16.13.3 The Medicines Company Vitamin K Antagonists (VKA) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Vitamin K Antagonists (VKA) Manufacturing Cost Analysis
17.1 Vitamin K Antagonists (VKA) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Vitamin K Antagonists (VKA)
17.4 Vitamin K Antagonists (VKA) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Vitamin K Antagonists (VKA) Distributors List
18.3 Vitamin K Antagonists (VKA) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Vitamin K Antagonists (VKA) (2021-2026)
20.2 Global Forecasted Revenue of Vitamin K Antagonists (VKA) (2021-2026)
20.3 Global Forecasted Price of Vitamin K Antagonists (VKA) (2015-2026)
20.4 Global Forecasted Production of Vitamin K Antagonists (VKA) by Region (2021-2026)
20.4.1 North America Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.3 Europe Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.7 Africa Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.9 South America Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Vitamin K Antagonists (VKA) Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Vitamin K Antagonists (VKA) by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
21.2 East Asia Market Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
21.3 Europe Market Forecasted Consumption of Vitamin K Antagonists (VKA) by Countriy
21.4 South Asia Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
21.5 Southeast Asia Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
21.6 Middle East Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
21.7 Africa Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
21.8 Oceania Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
21.9 South America Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
21.10 Rest of the world Forecasted Consumption of Vitamin K Antagonists (VKA) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer